Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study - Portenoy, R K; Thomas, J; Moehl Boatwright, M L (J Pain Symptom Manage, 2008)
et al.